Altria Group CEO Cites FDA Regulatory Delays and Market Competition Challenges
MO Altria Group Inc
$77.46 -1.83%
View chart & analysis → - 1Altria Group CEO Sal Mansucco explained difficulties regarding the pace of regulatory approvals and market competition.
- 2While the FDA must complete reviews within 180 days of a new tobacco product application submission, some cases take six years.
- 3Altria Group filed a lawsuit against the FDA last September, and Judge James Wesley Hendricks approved a request to stay the lawsuit last month.
So what's the key point?
The head of Altria Group said the process for getting new tobacco products approved is too slow and competition is difficult. The company filed a lawsuit against the regulatory agency, but a court recently accepted a request to pause the legal action.
Source Fortune · View original ↗
Nothing hidden: past picks and how they did against the S&P 500.